Dobbs to give plenary keynote at Drug Information Association conference in Philadelphia, Sept. 26

Stevens' pharma management expert to address four groups at session

HOBOKEN, N.J. - Dr. Joel H. Dobbs, Executive-in-Residence and Program Director, Pharmaceutical Management, at Stevens Institute of Technology's Howe School, will deliver the plenary keynote address, "Four Questions about Pharma's Future (and Yours)," Tues., Sept. 26, at the Drug Information Association Conference, located at the Sheraton Philadelphia City Center, Philadelphia, Penn. (Please visit

The conference brings together four groups: drug-development project management professionals, experts in outsourcing, clinical data managers and regulatory professionals who deal with global electronic product labeling. The goal of the plenary session is to address the challenges and opportunities facing the global biopharmaceutical industry and its people.

"To say that the pharmaceutical industry is going through a period of both challenge and change is, at best, a gross understatement," said Dobbs. "This industry, once a safe haven for investors and a stable and safe place to work, has suddenly become susceptible to a torrent of forces that are changing it in ways many of us might never have imagined only a few years ago. Pharmaceutical stocks that once led the S&P 500 in growth and stability now trail the pack. Between 1989 and 2005 twenty three well-known names in the industry merged into just eight mega companies and a new generation of small, innovative companies have emerged from the rubble of these mergers. Amid all of this, partnerships, licensing agreements and strategic alliances abound. This is a challenging time that requires leadership at all levels."


About Dr. Joel H. Dobbs

Prior to his retirement in 2004, Joel Dobbs was Vice President, Research Information Services and Global IT Strategy and Compliance for Schering-Plough Corporation. In this capacity, he was responsible for all information technology for the Schering-Plough Research Institute as well as for strategy and IT regulatory compliance globally. Prior to joining Schering-Plough, Dr. Dobbs spent 12 years with Glaxo Inc. in various management and executive positions in regulatory affairs, medical services and information services. He also spent one year with Glaxo Wellcome as Worldwide Director, Information Management and Analysis.

Dobbs has also served as a professor of pharmacy at Samford University and as Vice President and a Managing Partner for Pharmacy Specialties, Inc., a pharmacy management-consulting firm. He has served as a consultant to several organizations including one of the world's largest software companies and several small to midsize software and pharmaceutical companies.

Dobbs is past chair of PhRMA's Information Management Policy and Coordinating Committee and past chair of the Pharmaceutical Research Information Executive Forum. He serves on the Boards of several nonprofit organizations and has previously served on the editorial boards of the Annals of harmacotherapy, the Drug Information Journal, and Applied Clinical Trials. Dobbs received a Bachelor of Science degree in pharmacy from Samford University, a Master of Public Health degree from the University of Alabama in Birmingham, and a doctorate in pharmacy from the University of Tennessee. He has completed executive programs at Duke University's Fuqua School of Business and MIT.

For more information of Stevens Institute of Technology's Graduate Pharmaceutical Management Program, please visit

About Stevens Institute of Technology

Established in 1870, Stevens offers baccalaureate, masters and doctoral degrees in engineering, science, computer science, management and technology management, as well as a baccalaureate in the humanities and liberal arts, and in business and technology. Located directly across the Hudson River from Manhattan, the university has enrollments of approximately 1,780 undergraduates and 2,700 graduate students, and a current enrollment of 2,250 online-learning students worldwide. Additional information may be obtained from its web page at For the latest news about Stevens, please visit

Last reviewed: By John M. Grohol, Psy.D. on 30 Apr 2016
    Published on All rights reserved.